Similarly, expression analysis of Th17-associated genes in pre-treatment melanoma patient samples revealed that upregulation of IL17RC mRNA correlated with progressive or stable disease, whereas lower IL17RC mRNA correlated with partial or complete response to anti-PD-1 (Fig. 5b). Here, IL17RC is linked to melanoma.